HomeCompareFRNV vs MRK

FRNV vs MRK: Dividend Comparison 2026

FRNV yields 2000000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FRNV wins by $1.6247481716182984e+23M in total portfolio value
10 years
FRNV
FRNV
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.6247481716182984e+23M
Annual income
$147,608,011,402,949,780,000,000,000,000.00
Full FRNV calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — FRNV vs MRK

📍 FRNV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFRNVMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FRNV + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FRNV pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FRNV
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$125,466,809,692,507,310,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, FRNV beats the other by $125,466,809,692,507,310,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FRNV + MRK for your $10,000?

FRNV: 50%MRK: 50%
100% MRK50/50100% FRNV
Portfolio after 10yr
$8.123740858091492e+22M
Annual income
$73,804,005,701,474,890,000,000,000,000.00/yr
Blended yield
90.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FRNV
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FRNV buys
0
MRK buys
0
No recent congressional trades found for FRNV or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFRNVMRK
Forward yield2000000.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$1.6247481716182984e+23M$56.8K
Annual income after 10y$147,608,011,402,949,780,000,000,000,000.00$9,798.13
Total dividends collected$1.6146053563276882e+23M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FRNV vs MRK ($10,000, DRIP)

YearFRNV PortfolioFRNV Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$100,010,700$100,000,000.00$11,206$366.19+$100.00MFRNV
2$467,446,731,075$467,339,719,626.17$12,650$502.35+$467446.72MFRNV
3$1,021,215,363,816,662$1,020,715,195,814,411.90$14,407$694.19+$1021215363.80MFRNV
4$1,043,112,617,104,109,200$1,042,019,916,664,825,300.00$16,585$967.82+$1043112617104.09MFRNV
5$498,482,143,759,731,400,000$497,366,013,259,430,040,000.00$19,342$1,363.89+$498482143759731.38MFRNV
6$111,599,275,650,097,780,000,000$111,065,899,756,274,860,000,000.00$22,913$1,947.19+$111599275650097776.00MFRNV
7$11,738,678,336,351,557,000,000,000$11,619,267,111,405,953,000,000,000.00$27,662$2,823.89+$11738678336351557632.00MFRNV
8$583,674,362,697,175,100,000,000,000$571,113,976,877,278,900,000,000,000.00$34,159$4,173.35+$583674362697175072768.00MFRNV
9$13,894,210,989,607,547,000,000,000,000$13,269,679,421,521,570,000,000,000,000.00$43,337$6,308.80+$1.3894210989607547e+22MFRNV
10$162,474,817,161,829,840,000,000,000,000$147,608,011,402,949,780,000,000,000,000.00$56,776$9,798.13+$1.6247481716182984e+23MFRNV

FRNV vs MRK: Complete Analysis 2026

FRNVStock

Frontera Investment, Inc. provides various financial services to the un-banked and under-banked financial services customers. The company offers check cashing services, including payroll, tax checks, government checks, insurance drafts, cashier's checks, business checks, and other check cashing services; payday loans, cash advances, and payday advances; auto title, car title, and pink slip loans; gold buying and selling; pawn loans; money transfer services as an agent for Western Union; bill pay services; and money orders as an agent. It also provides currency exchange, international faxing, prepaid cellular, notary, and lottery services; and phone cards, post office boxes, stamps and copies, and photo membership cards. As of September 30, 2014, the company operated 13 full service stores, including 12 stores located in California and 1 store in Florida. Frontera Investment, Inc. is based in Poway, California.

Full FRNV Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this FRNV vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FRNV vs SCHDFRNV vs JEPIFRNV vs OFRNV vs KOFRNV vs MAINFRNV vs JNJFRNV vs ABBVFRNV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.